Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Laboratoires Bouchara-Recordati is a French pharmaceutical company headquartered in Puteaux, France. Originally founded as Laboratoires Bouchara in 1929 by Emile Bouchara, the company was acquired by the Italian pharmaceutical group Recordati in 2000 and subsequently merged to form Laboratoires Bouchara-Recordati in 2001. The company specializes in the development, manufacturing, and commercialization of prescription medicines, over-the-counter (OTC) products, medical devices, and food supplements. Its core therapeutic areas include cardiology, urology, gynecology, pulmonology, and addiction treatments, with well-known products such as Methadone (for opioid dependency), Polydexa (for ear infections), and Ginkor Fort (for venous circulation).
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Laboratoires Bouchara.